Clinical Trial Update: Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/Phase 2 clinical trial is evaluating the safety and efficacy of AGN-INM176 in prostate cancer patients with rising PSA, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• AGN-INM176

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING